Acadia Healthcare (NASDAQ:ACHC) Reaches New 1-Year High After Analyst Upgrade

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) reached a new 52-week high during trading on Monday after Guggenheim raised their price target on the stock from $26.00 to $31.00. Guggenheim currently has a buy rating on the stock. Acadia Healthcare traded as high as $28.74 and last traded at $29.0760, with a volume of 17545 shares traded. The stock had previously closed at $27.85.

Other equities research analysts also recently issued research reports about the stock. Zacks Research upgraded shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research report on Thursday, March 5th. Royal Bank Of Canada boosted their target price on Acadia Healthcare from $17.00 to $28.00 and gave the stock an “outperform” rating in a research report on Thursday, February 26th. Raymond James Financial raised Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target for the company in a report on Monday. Barclays lifted their price target on Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday. Finally, Cantor Fitzgerald increased their price objective on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $25.81.

Institutional Investors Weigh In On Acadia Healthcare

Institutional investors have recently modified their holdings of the company. EverSource Wealth Advisors LLC increased its stake in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares in the last quarter. Wells Fargo & Company MN boosted its position in Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after purchasing an additional 1,510 shares in the last quarter. Bayforest Capital Ltd purchased a new stake in Acadia Healthcare during the fourth quarter worth $52,000. Hantz Financial Services Inc. grew its holdings in Acadia Healthcare by 501.9% in the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after purchasing an additional 1,822 shares during the last quarter. Finally, GAMMA Investing LLC increased its position in shares of Acadia Healthcare by 124.7% in the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after buying an additional 2,698 shares in the last quarter.

Acadia Healthcare Stock Up 3.6%

The firm has a market cap of $2.65 billion, a price-to-earnings ratio of -2.37, a P/E/G ratio of 9.39 and a beta of 0.73. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The firm has a 50 day moving average price of $24.43 and a 200-day moving average price of $19.12.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The firm had revenue of $828.80 million for the quarter, compared to analysts’ expectations of $823.51 million. During the same period in the prior year, the company earned $0.40 EPS. The firm’s revenue was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, equities analysts forecast that Acadia Healthcare Company, Inc. will post 1.48 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.